|1.||Cheng, Hsiu-Min: 1 article (01/2011)|
|2.||Hung, Hui-Shan: 1 article (01/2011)|
|3.||Chen, Tsan-Ju: 1 article (01/2011)|
|4.||Wang, Dean-Chuan: 1 article (01/2011)|
|5.||Yasui, Hiroyuki: 1 article (02/2006)|
|6.||Kaneko, Noritsugu: 1 article (02/2006)|
|7.||Sakurai, Hiromu: 1 article (02/2006)|
|8.||Takada, Jitsuya: 1 article (02/2006)|
|9.||Johnson, Victor J: 1 article (02/2005)|
|10.||Sharma, Raghubir P: 1 article (02/2005)|
|1.||Alzheimer Disease (Alzheimer's Disease)
06/08/2001 - "Investigations in our laboratory have focused on neuronal injury resulting from the intracisternal administration of aluminum maltolate to New Zealand white rabbits, an animal system relevant to a study of human disease in that it reflects many of the histological and biochemical changes associated with Alzheimer's disease. "
12/01/1998 - "We propose that the aluminum maltolate-treated elderly rabbit is a potentially useful animal system to model Alzheimer's disease neurofibrillary pathology. "
01/29/1996 - "The monoclonal antibody Alz-50 which recognizes a phosphorylation-independent epitope of tau in Alzheimer's disease paired helical filaments, demonstrates positivity in the aluminum maltolate-treated rabbits by day 3. Other tau monoclonal antibodies which recognize phosphorylated tau in paired helical filaments (AT8 and PHF-1) show positive immunostaining on days 6-8. These results indicate that intraneuronal aggregation of cytoskeletal proteins can be initiated by factors other than phosphorylation. "
|4.||Memory Disorders (Memory Loss)
|1.||Brain-Derived Neurotrophic Factor (BDNF)